News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
248,573 Results
Type
Article (6145)
Company Profile (23)
Press Release (242405)
Section
Business (88468)
Career Advice (472)
Deals (16585)
Drug Delivery (10)
Drug Development (21719)
Employer Resources (33)
FDA (4092)
Job Trends (4636)
News (131132)
Policy (8491)
Tag
2024 BioCapital Digital (2)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (1)
2024 Pharm Country Digital (2)
2025 Lone Star Bio Digital (1)
Academia (382)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (16518)
ALS (24)
Alzheimer's disease (334)
Antibody-drug conjugate (ADC) (15)
Approvals (4115)
Artificial intelligence (50)
Autoimmune disease (5)
Automation (3)
Bankruptcy (107)
Best Places to Work (3474)
Biosimilars (12)
Biotechnology (30)
Bladder cancer (11)
Brain cancer (8)
Breast cancer (74)
Cancer (550)
Cardiovascular disease (30)
Career advice (404)
Career pathing (4)
CAR-T (34)
Cell therapy (116)
Cervical cancer (2)
Clinical research (18112)
Collaboration (207)
Compensation (171)
Complete response letters (3)
COVID-19 (461)
CRISPR (14)
C-suite (115)
Cystic fibrosis (19)
Data (609)
Depression (9)
Diabetes (49)
Diagnostics (2383)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (27)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (16)
Earnings (43026)
Editorial (2)
Employer branding (6)
Employer resources (33)
Events (41217)
Executive appointments (336)
FDA (4373)
Featured Employer (7)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (233)
Gene editing (26)
Generative AI (2)
Gene therapy (58)
GLP-1 (128)
Government (522)
Guidances (18)
Healthcare (5694)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (481)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (57)
IPO (8467)
IRA (3)
Job creations (1265)
Job search strategy (366)
Kidney cancer (7)
Labor market (5)
Layoffs (107)
Leadership (5)
Legal (2680)
Liver cancer (17)
Lung cancer (62)
Lymphoma (34)
Management (11)
Manufacturing (57)
MASH (28)
Medical device (4314)
Medtech (4316)
Mergers & acquisitions (8359)
Metabolic disorders (133)
Multiple sclerosis (14)
NASH (6)
Neurodegenerative disease (12)
Neuropsychiatric disorders (2)
Neuroscience (456)
NextGen: Class of 2025 (1824)
Non-profit (828)
Northern California (995)
Now hiring (3)
Obesity (56)
Opinion (33)
Ovarian cancer (17)
Pain (17)
Pancreatic cancer (22)
Parkinson's disease (29)
Partnered (8)
Patents (30)
Patient recruitment (33)
Peanut (5)
People (26740)
Pharmaceutical (8)
Pharmacy benefit managers (1)
Phase I (5412)
Phase II (8025)
Phase III (6179)
Pipeline (589)
Policy (9)
Postmarket research (660)
Preclinical (2205)
Press Release (67)
Prostate cancer (30)
Psychedelics (5)
Radiopharmaceuticals (123)
Rare diseases (78)
Real estate (2029)
Recruiting (9)
Regulatory (5712)
Reports (15)
Research institute (396)
Resumes & cover letters (68)
Rett syndrome (4)
RNA editing (1)
Schizophrenia (28)
Series A (31)
Series B (26)
Service/supplier (2)
Sickle cell disease (8)
Southern California (747)
Special edition (1)
Spinal muscular atrophy (30)
Sponsored (6)
Startups (1145)
State (1)
Stomach cancer (1)
Supply chain (12)
Tariffs (5)
United States (7906)
Vaccines (60)
Venture capitalists (3)
Weight loss (23)
Women's health (2)
Date
Today (48)
Last 7 days (253)
Last 30 days (812)
Last 365 days (11343)
2025 (3603)
2024 (12484)
2023 (14822)
2022 (20770)
2021 (22146)
2020 (19965)
2019 (14528)
2018 (11184)
2017 (11074)
2016 (10211)
2015 (13402)
2014 (10518)
2013 (8470)
2012 (9181)
2011 (9561)
2010 (9335)
Location
Africa (201)
Alabama (14)
Alaska (2)
Arizona (67)
Arkansas (1)
Asia (12354)
Australia (1705)
California (2102)
Canada (1104)
China (85)
Colorado (93)
Connecticut (99)
Delaware (38)
Europe (26636)
Florida (297)
Georgia (39)
Idaho (23)
Illinois (127)
India (7)
Indiana (81)
Iowa (2)
Japan (82)
Kansas (25)
Kentucky (11)
Louisiana (5)
Maine (40)
Maryland (234)
Massachusetts (1701)
Michigan (105)
Minnesota (148)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (14)
Nevada (28)
New Hampshire (24)
New Jersey (720)
New Mexico (8)
New York (540)
North Carolina (367)
North Dakota (4)
Northern California (995)
Ohio (60)
Oklahoma (7)
Oregon (4)
Pennsylvania (392)
Puerto Rico (2)
Rhode Island (13)
South America (309)
South Carolina (5)
Southern California (747)
Tennessee (44)
Texas (282)
Utah (66)
Virginia (46)
Washington D.C. (10)
Washington State (201)
West Virginia (2)
Wisconsin (34)
248,573 Results for "zenith epigenetics corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Zenith Epigenetics Proudly Supports Rare Disease Day
Zenith Epigenetics Ltd. (“Zenith” or the “Company”) announces its support of Rare Disease Day by highlighting our expanded development efforts of BET inhibitor ZEN-3694
February 29, 2024
·
5 min read
Press Releases
Zenith Capital Corp. Provides Update on the Company’s Upcoming Annual General Meeting
December 16, 2024
·
5 min read
Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
Zenith Epigenetics Ltd. (“Zenith” or the “Company”), a global leader in epigenetics, announced today it has entered into an agreement with Cencora (formerly AmerisourceBergen) aimed at accelerating the commercialization of Zenith Epigenetics’ ZEN-3694 program.
October 26, 2023
·
7 min read
Press Releases
Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
September 24, 2024
·
3 min read
Zenith Epigenetics Reports Advancement of ZEN-3694 in NUT Carcinoma
Zenith Epigenetics Ltd. (“Zenith” or the “Company”) reports clinical activity and the advancement in development of its BET inhibitor (BETi) ZEN-3694 in patients with NUT carcinoma (NC). NC is a highly aggressive type of squamous cell cancer with very poor prognosis that often forms in the head, neck, or lungs.
June 1, 2023
·
6 min read
Press Releases
WINREVAIR™ (sotatercept-csrk) Reduced the Risk of a Composite of All-Cause Death, Lung Transplantation and Hospitalization for Pulmonary Arterial Hypertension (PAH) by 76% Compared to Placebo in the Phase 3 ZENITH Trial
March 31, 2025
·
12 min read
Press Releases
180 Life Sciences Corp. Announces Share Repurchase
April 30, 2025
·
7 min read
Pharm Country
West Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy
West Pharmaceutical Services, Inc. announced that it will unveil its new Daikyo Crystal Zenith® Nested Vials in Tub at the International Society for Cell and Gene Therapy Annual Meeting taking place in Vancouver, Canada from May 29- June 1.
May 29, 2024
·
2 min read
Press Releases
Medline receives AARC’s 2024 Zenith Award for dedication to respiratory care
October 2, 2024
·
2 min read
Press Releases
OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System
April 9, 2025
·
2 min read
1 of 24,858
Next
